Found 160 matching trials
Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies PHASE1 The primary purpose of this study is to determine the safety and efficacy o...
Show More Location
The Affiliated People's Hospital of Ningbo University
Learn More & Join Trial
Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-meso PHASE1 RATIONALE: Placing a tumor antigen chimeric receptor that has been created ...
Show More Location
Biotherapeutic Department and Pediatrics Department of Chinese PLA General Hospital
Learn More & Join Trial
CD4 CAR+ ZFN-modified T Cells in HIV Therapy PHASE1 This research study is being carried out to study a new way to possibly tre...
Show More Status
Active Not Recruiting
Location
University of Pennsylvania
Learn More & Join Trial
Genetically Modified T-cells in Treating Patients With Recurrent or Refractory Malignant Glioma PHASE1 This phase I trial studies the side effects and best dose of genetically mo...
Show More Status
Active Not Recruiting
Location
City of Hope Medical Center
Learn More & Join Trial
Treatment of Chemotherapy Refractory Multiple Myeloma by CART-138 PHASE1 RATIONALE: Placing a tumor antigen chimeric receptor that has been created ...
Show More Location
Chinese PLA General Hospital
Learn More & Join Trial
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma PHASE2 This phase II trial tests whether mosunetuzumab and/or polatuzumab vedotin ...
Show More Location
Banner University Medical Center - Tucson
Learn More & Join Trial
Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent or High-Risk Non-Hodgkin Lymphoma PHASE1 This phase I trial studies the side effects and best dose of genetically mo...
Show More Status
Active Not Recruiting
Location
City of Hope Medical Center
Learn More & Join Trial
SPEARHEAD 2 Study in Subjects With Recurrent or Metastatic Head and Neck Cancer PHASE2 This is a study to investigate the efficacy and safety of ADP-A2M4 in combi...
Show More Location
Mayo Clinic Phoenix
Learn More & Join Trial
Long-term Follow-up of Study Participant Treated With Lentiviral-Based Genetically Modified Autologous Cell Product ,AGT103-T N/A Long-term follow-up of study subjects who received AGT103-T product in HIV ...
Show More Status
Enrolling By Invitation
Location
Georgetown University
Learn More & Join Trial
TAA6 Cell Injection In The Treatment of Patients With Relapsed / Refractory Acute Myeloid Leukemia NA This is a clinical study of TAA6 cell injection in the treatment of patient...
Show More Location
Anhui Provincial Hospital
Learn More & Join Trial